West Pharma (WST) Misses Q1 EPS by 2c, Beats on Revenues; Offers FY18 EPS/Revenue Mid-Point Outlooks Above Consenus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| WEST PHARMACEUTICAL SERVICES, Inc. (NYSE: WST) | Delayed: 391.66 -2.37 (0.6%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $394.03 | 52 Week High | $84.33 | |||
| Open | $391.60 | 52 Week Low | $53.88 | |||
| Day High | $394.18 | P/E | 249.46 | |||
| Day Low | $390.83 | EPS | $1.57 | |||
| Volume | 113,020 | |||||
